FPRX

FIVE PRIME THERAPEUTICS, INC.CIK 1175505 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for FPRX PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for FPRX

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Civik Thomas	President and CEO	5	$0	$0	2021-04-16
Collins Helen Louise	SVP and Chief Medical Officer	48	$0	$0	2021-04-16
Lyons-Williams Lori	Director	4	$0	$0	2021-04-16
Nicholson Garry A	Director	8	$0	$0	2021-04-16
Jensen Peder	Director	21	$0	$1.05M	2021-04-16
Dhingra Kapil	Director	11	$0	$0	2021-04-16
Sarena Francis Willard	SVP, Gen Counsel & Secretary	102	$0	$3.82M	2021-04-16
White David	See Remarks	12	$0	$0	2021-04-16
BERGER FRANKLIN M	Director	36	$1.51M	$317.4K	2021-04-16
SCHAFER CAROL	Director	6	$0	$0	2021-04-16
RINGO WILLIAM R	Interim CEO	73	$0	$2.15M	2021-04-16
Smith David V	Executive Vice President & CFO	21	$0	$0	2021-04-16
BIOTECHNOLOGY VALUE FUND L P	Other	6	$3.81M	$149.27M	2020-11-11
BVF II GP LLC	Other	6	$2.18M	$0	2020-11-06
BVF GP HOLDINGS LLC	10% Owner	3	$1.74M	$0	2020-10-06
BVF INC/IL	10% Owner	11	$1.84M	$0	2020-09-22
BVF Partners OS Ltd.	Other	3	$2.09M	$0	2019-12-20
Biotechnology Value Trading Fund OS LP	Other	15	$2.79M	$0	2019-12-09
BIOTECHNOLOGY VALUE FUND II LP	Other	3	$3.87M	$0	2019-11-05
LAMPERT MARK N	10% Owner	9	$113.8K	$0	2019-10-31
Knickerbocker Aron Marc	SVP & Chief Business Officer	98	$0	$0	2019-09-01
Williams Lewis T	President, CEO and Chairman	96	$0	$15.00M	2019-09-01
Irving Bryan	SVP, Research	13	$0	$0	2019-05-15
Gujrathi Sheila	Director	4	$0	$0	2018-05-10
MCDADE MARK	Director	10	$0	$0	2018-05-10
Baker Kevin Paul	SVP, Development Sciences	11	$0	$0	2018-02-26
Belsky Marc	Senior Vice President and CFO	41	$0	$3.20M	2018-02-26
Cohen Fred E	Director	14	$0	$0	2017-05-10
Borges Luis	SVP, Research	7	$0	$0	2017-03-01
Sikorski Robert Steven	SVP and Chief Medical Officer	10	$0	$0	2017-03-01
Douglas R Lee	Director	9	$0	$0	2016-10-12
Hambleton Julie	SVP & Chief Medical Officer	16	$22.0K	$800.2K	2015-11-11
ADAGE CAPITAL PARTNERS GP LLC	10% Owner	4	$0	$3.47M	2015-10-15
ATWOOD BRIAN G	Director	7	$1000.0K	$0	2015-06-12
Kavanaugh William Michael	SVP & Chief Scientific Officer	1	$0	$0	2014-08-22

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Civik Thomas	President and CEO	D To issuer deriv	2021-04-16	2021-04-19	480,000	—	$0	0	SEC↗
Lyons-Williams Lori	Director	D To issuer deriv	2021-04-16	2021-04-19	20,000	—	$0	0	SEC↗
Lyons-Williams Lori	Director	D To issuer deriv	2021-04-16	2021-04-19	25,000	—	$0	0	SEC↗
SCHAFER CAROL	Director	D To issuer deriv	2021-04-16	2021-04-19	1,250	—	$0	0	SEC↗
SCHAFER CAROL	Director	D To issuer deriv	2021-04-16	2021-04-19	25,000	—	$0	0	SEC↗
SCHAFER CAROL	Director	D To issuer deriv	2021-04-16	2021-04-19	20,000	—	$0	0	SEC↗
Nicholson Garry A	Director	D To issuer deriv	2021-04-16	2021-04-19	15,000	—	$0	0	SEC↗
Nicholson Garry A	Director	D To issuer deriv	2021-04-16	2021-04-19	10,000	—	$0	0	SEC↗
Nicholson Garry A	Director	D To issuer deriv	2021-04-16	2021-04-19	15,000	—	$0	0	SEC↗
Nicholson Garry A	Director	D To issuer deriv	2021-04-16	2021-04-19	20,000	—	$0	0	SEC↗
Jensen Peder	Director	D To issuer deriv	2021-04-16	2021-04-19	10,000	—	$0	0	SEC↗
Jensen Peder	Director	D To issuer deriv	2021-04-16	2021-04-19	15,000	—	$0	0	SEC↗
Jensen Peder	Director	D To issuer deriv	2021-04-16	2021-04-19	10,000	—	$0	0	SEC↗
Jensen Peder	Director	D To issuer deriv	2021-04-16	2021-04-19	20,000	—	$0	0	SEC↗
Jensen Peder	Director	D To issuer deriv	2021-04-16	2021-04-19	12,500	—	$0	0	SEC↗
Jensen Peder	Director	D To issuer deriv	2021-04-16	2021-04-19	12,500	—	$0	0	SEC↗
Dhingra Kapil	Director	D To issuer deriv	2021-04-16	2021-04-19	10,000	—	$0	0	SEC↗
Dhingra Kapil	Director	D To issuer deriv	2021-04-16	2021-04-19	15,000	—	$0	0	SEC↗
Dhingra Kapil	Director	D To issuer deriv	2021-04-16	2021-04-19	20,000	—	$0	0	SEC↗
Dhingra Kapil	Director	D To issuer deriv	2021-04-16	2021-04-19	10,000	—	$0	0	SEC↗
Dhingra Kapil	Director	D To issuer deriv	2021-04-16	2021-04-19	25,000	—	$0	0	SEC↗
BERGER FRANKLIN M	Director	D To issuer deriv	2021-04-16	2021-04-19	12,500	—	$0	0	SEC↗
BERGER FRANKLIN M	Director	D To issuer deriv	2021-04-16	2021-04-19	10,000	—	$0	0	SEC↗
BERGER FRANKLIN M	Director	D To issuer deriv	2021-04-16	2021-04-19	10,000	—	$0	0	SEC↗
BERGER FRANKLIN M	Director	D To issuer deriv	2021-04-16	2021-04-19	20,000	—	$0	0	SEC↗
BERGER FRANKLIN M	Director	D To issuer deriv	2021-04-16	2021-04-19	15,000	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2021-04-16	2021-04-19	46,939	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2021-04-16	2021-04-19	52,408	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2021-04-16	2021-04-19	37,998	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2021-04-16	2021-04-19	40,868	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2021-04-16	2021-04-19	49,552	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2021-04-16	2021-04-19	50,367	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2021-04-16	2021-04-19	27,769	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2021-04-16	2021-04-19	34,451	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2021-04-16	2021-04-19	15,000	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2021-04-16	2021-04-19	10,000	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2021-04-16	2021-04-19	10,000	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2021-04-16	2021-04-19	12,500	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2021-04-16	2021-04-19	16,600	—	$0	0	SEC↗
White David	See Remarks	D To issuer deriv	2021-04-16	2021-04-19	30,000	—	$0	0	SEC↗
White David	See Remarks	D To issuer deriv	2021-04-16	2021-04-19	25,000	—	$0	0	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	D To issuer deriv	2021-04-16	2021-04-19	60,000	—	$0	0	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	D To issuer deriv	2021-04-16	2021-04-19	58,000	—	$0	0	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	D To issuer deriv	2021-04-16	2021-04-19	50,000	—	$0	0	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	D To issuer deriv	2021-04-16	2021-04-19	20,000	—	$0	0	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	D To issuer deriv	2021-04-16	2021-04-19	90,000	—	$0	0	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	D To issuer deriv	2021-04-16	2021-04-19	90,000	—	$0	0	SEC↗
Smith David V	Executive Vice President & C	D To issuer deriv	2021-04-16	2021-04-19	90,000	—	$0	0	SEC↗
Smith David V	Executive Vice President & C	D To issuer deriv	2021-04-16	2021-04-19	90,000	—	$0	0	SEC↗
Smith David V	Executive Vice President & C	D To issuer deriv	2021-04-16	2021-04-19	185,000	—	$0	0	SEC↗
Sarena Francis Willard	Chief Strategy Officer	D To issuer deriv	2021-04-16	2021-04-19	90,000	—	$0	0	SEC↗
Sarena Francis Willard	Chief Strategy Officer	D To issuer deriv	2021-04-16	2021-04-19	90,000	—	$0	0	SEC↗
Sarena Francis Willard	Chief Strategy Officer	D To issuer deriv	2021-04-16	2021-04-19	58,000	—	$0	0	SEC↗
Sarena Francis Willard	Chief Strategy Officer	D To issuer deriv	2021-04-16	2021-04-19	45,000	—	$0	0	SEC↗
Sarena Francis Willard	Chief Strategy Officer	D To issuer deriv	2021-04-16	2021-04-19	75,000	—	$0	0	SEC↗
Sarena Francis Willard	Chief Strategy Officer	D To issuer deriv	2021-04-16	2021-04-19	25,521	—	$0	0	SEC↗
Sarena Francis Willard	Chief Strategy Officer	D To issuer deriv	2021-04-16	2021-04-19	3,209	—	$0	0	SEC↗
Sarena Francis Willard	Chief Strategy Officer	D To issuer deriv	2021-04-16	2021-04-19	4,747	—	$0	0	SEC↗
Sarena Francis Willard	Chief Strategy Officer	D To issuer deriv	2021-04-16	2021-04-19	9,142	—	$0	0	SEC↗
Sarena Francis Willard	Chief Strategy Officer	D To issuer deriv	2021-04-16	2021-04-19	12,063	—	$0	0	SEC↗
Civik Thomas	President and CEO	D To issuer	2021-04-16	2021-04-19	68,971	$38.00	$2.62M	0	SEC↗
BERGER FRANKLIN M	Director	D To issuer	2021-04-16	2021-04-19	5,000	$38.00	$190.0K	0	SEC↗
White David	See Remarks	D To issuer	2021-04-16	2021-04-19	33,423	$38.00	$1.27M	0	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	D To issuer	2021-04-16	2021-04-19	135,547	$38.00	$5.15M	0	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	A Award	2021-04-16	2021-04-19	66,000	—	$0	135,547	SEC↗
Smith David V	Executive Vice President & C	D To issuer	2021-04-16	2021-04-19	138,947	$38.00	$5.28M	0	SEC↗
Smith David V	Executive Vice President & C	A Award	2021-04-16	2021-04-19	66,000	—	$0	138,947	SEC↗
Sarena Francis Willard	Chief Strategy Officer	D To issuer	2021-04-16	2021-04-19	795	$38.00	$30.2K	0	SEC↗
Sarena Francis Willard	Chief Strategy Officer	D To issuer	2021-04-16	2021-04-19	795	$38.00	$30.2K	0	SEC↗
Sarena Francis Willard	Chief Strategy Officer	D To issuer	2021-04-16	2021-04-19	795	$38.00	$30.2K	0	SEC↗
Sarena Francis Willard	Chief Strategy Officer	D To issuer	2021-04-16	2021-04-19	169,468	$38.00	$6.44M	0	SEC↗
Sarena Francis Willard	Chief Strategy Officer	A Award	2021-04-16	2021-04-19	66,000	—	$0	169,468	SEC↗
Civik Thomas	President and CEO	F Tax w/h	2021-04-09	2021-04-13	11,088	$37.94	$420.7K	68,971	SEC↗
Sarena Francis Willard	Chief Strategy Officer	G Gift	2021-04-06	2021-04-19	14,174	—	$0	103,468	SEC↗
RINGO WILLIAM R	Director	G Gift	2021-04-05	2021-04-19	10,000	—	$0	0	SEC↗
Sarena Francis Willard	Chief Strategy Officer	G Gift	2021-04-05	2021-04-19	2,460	—	$0	117,642	SEC↗
Sarena Francis Willard	Chief Strategy Officer	G Gift	2021-04-01	2021-04-19	2,385	—	$0	121,542	SEC↗
Sarena Francis Willard	Chief Strategy Officer	G Gift	2021-04-01	2021-04-19	1,440	—	$0	120,102	SEC↗
Sarena Francis Willard	Chief Strategy Officer	G Gift	2021-04-01	2021-04-19	795	—	$0	795	SEC↗
Sarena Francis Willard	Chief Strategy Officer	G Gift	2021-04-01	2021-04-19	795	—	$0	795	SEC↗
Sarena Francis Willard	Chief Strategy Officer	G Gift	2021-04-01	2021-04-19	795	—	$0	795	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	G Gift	2021-03-31	2021-04-19	8,085	—	$0	69,547	SEC↗
White David	See Remarks	F Tax w/h	2021-02-28	2021-03-02	1,461	$22.23	$32.5K	33,423	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	F Tax w/h	2021-02-26	2021-03-02	1,158	$22.23	$25.7K	77,632	SEC↗
Sarena Francis Willard	Chief Strategy Officer	F Tax w/h	2021-02-26	2021-03-02	1,158	$22.23	$25.7K	123,433	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	F Tax w/h	2021-02-25	2021-02-26	1,653	$23.08	$38.2K	78,790	SEC↗
Sarena Francis Willard	Chief Strategy Officer	F Tax w/h	2021-02-25	2021-02-26	1,653	$23.08	$38.2K	124,591	SEC↗
White David	See Remarks	F Tax w/h	2021-02-24	2021-02-26	1,155	$25.71	$29.7K	34,884	SEC↗
Smith David V	Executive Vice President & C	F Tax w/h	2021-02-24	2021-02-26	5,110	$25.71	$131.4K	72,947	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	F Tax w/h	2021-02-24	2021-02-26	5,091	$25.71	$130.9K	80,443	SEC↗
Sarena Francis Willard	Chief Strategy Officer	F Tax w/h	2021-02-24	2021-02-26	5,100	$25.71	$131.1K	126,244	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	M Exercise deriv	2020-12-11	2020-12-15	22,000	—	$0	0	SEC↗
Smith David V	Executive Vice President & C	M Exercise deriv	2020-12-11	2020-12-15	22,000	—	$0	0	SEC↗
Sarena Francis Willard	Chief Strategy Officer	M Exercise deriv	2020-12-11	2020-12-15	22,000	—	$0	0	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	F Tax w/h	2020-12-11	2020-12-15	11,583	$16.14	$186.9K	85,534	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	M Exercise	2020-12-11	2020-12-15	22,000	—	$0	97,117	SEC↗
Smith David V	Executive Vice President & C	M Exercise	2020-12-11	2020-12-15	22,000	—	$0	89,561	SEC↗
Smith David V	Executive Vice President & C	F Tax w/h	2020-12-11	2020-12-15	11,504	$16.14	$185.7K	78,057	SEC↗
Sarena Francis Willard	Chief Strategy Officer	M Exercise	2020-12-11	2020-12-15	22,000	—	$0	138,010	SEC↗
Sarena Francis Willard	Chief Strategy Officer	F Tax w/h	2020-12-11	2020-12-15	11,583	$16.14	$186.9K	126,427	SEC↗
Smith David V	Executive Vice President & C	F Tax w/h	2020-11-26	2020-11-30	6,920	$18.45	$127.7K	67,561	SEC↗
RINGO WILLIAM R	Director	M Exercise deriv	2020-11-11	2020-11-13	26,000	—	$0	52,408	SEC↗
RINGO WILLIAM R	Director	M Exercise deriv	2020-11-11	2020-11-13	52,959	—	$0	0	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	M Exercise deriv	2020-11-11	2020-11-13	22,000	—	$0	22,000	SEC↗
Smith David V	Executive Vice President & C	M Exercise deriv	2020-11-11	2020-11-13	22,000	—	$0	22,000	SEC↗
Sarena Francis Willard	Chief Strategy Officer	M Exercise deriv	2020-11-11	2020-11-13	22,000	—	$0	22,000	SEC↗
RINGO WILLIAM R	Director	M Exercise	2020-11-11	2020-11-13	26,000	$2.80	$72.8K	36,000	SEC↗
RINGO WILLIAM R	Director	S Sale	2020-11-11	2020-11-13	26,000	$22.50	$585.0K	10,000	SEC↗
RINGO WILLIAM R	Director	S Sale	2020-11-11	2020-11-13	52,959	$22.50	$1.19M	10,000	SEC↗
RINGO WILLIAM R	Director	M Exercise	2020-11-11	2020-11-13	52,959	$2.22	$117.6K	62,959	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	M Exercise	2020-11-11	2020-11-13	22,000	—	$0	86,156	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	F Tax w/h	2020-11-11	2020-11-13	11,039	$18.00	$198.7K	75,117	SEC↗
Smith David V	Executive Vice President & C	F Tax w/h	2020-11-11	2020-11-13	10,908	$18.00	$196.3K	74,481	SEC↗
Smith David V	Executive Vice President & C	M Exercise	2020-11-11	2020-11-13	22,000	—	$0	85,389	SEC↗
Sarena Francis Willard	Chief Strategy Officer	F Tax w/h	2020-11-11	2020-11-13	11,001	$18.00	$198.0K	116,010	SEC↗
Sarena Francis Willard	Chief Strategy Officer	M Exercise	2020-11-11	2020-11-13	22,000	—	$0	127,011	SEC↗
BIOTECHNOLOGY VALUE FUND L P	Other	S Sale	2020-11-11	2020-11-13	502,649	$20.19	$10.15M	81,263	SEC↗
BIOTECHNOLOGY VALUE FUND L P	Other	S Sale	2020-11-11	2020-11-13	2,949,477	$20.19	$59.55M	485,513	SEC↗
BIOTECHNOLOGY VALUE FUND L P	Other	S Sale	2020-11-11	2020-11-13	3,941,214	$20.19	$79.57M	670,695	SEC↗
BVF II GP LLC	Other	P Buy	2020-11-06	2020-11-06	2,334	$4.98	$11.6K	583,912	SEC↗
BVF II GP LLC	Other	P Buy	2020-11-06	2020-11-06	17,230	$4.98	$85.8K	4,611,909	SEC↗
BVF II GP LLC	Other	P Buy	2020-11-06	2020-11-06	10,436	$4.98	$52.0K	3,434,990	SEC↗
BVF II GP LLC	Other	P Buy	2020-11-04	2020-11-06	257,804	$4.88	$1.26M	4,594,679	SEC↗
BVF II GP LLC	Other	P Buy	2020-11-04	2020-11-06	143,403	$4.88	$699.8K	3,424,554	SEC↗
BVF II GP LLC	Other	P Buy	2020-11-04	2020-11-06	15,355	$4.88	$74.9K	581,578	SEC↗
BVF GP HOLDINGS LLC	10% Owner	P Buy	2020-10-06	2020-10-08	25,107	$5.04	$126.5K	566,223	SEC↗
BVF GP HOLDINGS LLC	10% Owner	P Buy	2020-10-06	2020-10-08	162,352	$5.04	$818.3K	3,281,151	SEC↗
BVF GP HOLDINGS LLC	10% Owner	P Buy	2020-10-06	2020-10-08	157,782	$5.04	$795.2K	4,336,875	SEC↗
White David	See Remarks	F Tax w/h	2020-09-30	2020-10-02	6,916	$4.70	$32.5K	36,039	SEC↗
BVF INC/IL	10% Owner	P Buy	2020-09-22	2020-09-24	32	$3.80	$122	541,116	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	F Tax w/h	2020-08-20	2020-08-24	827	$4.69	$3.9K	64,156	SEC↗
RINGO WILLIAM R	Director	A Award deriv	2020-05-19	2020-05-20	27,769	—	$0	27,769	SEC↗
Lyons-Williams Lori	Director	A Award deriv	2020-05-14	2020-05-15	20,000	—	$0	20,000	SEC↗
SCHAFER CAROL	Director	A Award deriv	2020-05-14	2020-05-15	20,000	—	$0	20,000	SEC↗
BERGER FRANKLIN M	Director	A Award deriv	2020-05-14	2020-05-15	20,000	—	$0	20,000	SEC↗
Dhingra Kapil	Director	A Award deriv	2020-05-14	2020-05-15	20,000	—	$0	20,000	SEC↗
Nicholson Garry A	Director	A Award deriv	2020-05-14	2020-05-15	20,000	—	$0	20,000	SEC↗
Jensen Peder	Director	A Award deriv	2020-05-14	2020-05-18	20,000	—	$0	20,000	SEC↗
BVF INC/IL	10% Owner	P Buy	2020-05-14	2020-05-18	39,810	$4.10	$163.2K	3,118,799	SEC↗
BVF INC/IL	10% Owner	P Buy	2020-05-14	2020-05-18	4,476	$4.10	$18.4K	541,084	SEC↗
BVF INC/IL	10% Owner	P Buy	2020-05-14	2020-05-18	249,301	$4.10	$1.02M	4,179,093	SEC↗
RINGO WILLIAM R	Director	A Award deriv	2020-04-19	2020-04-20	78,408	—	$0	78,408	SEC↗
Civik Thomas	President and CEO	A Award deriv	2020-04-13	2020-04-14	480,000	—	$0	480,000	SEC↗
Civik Thomas	President and CEO	A Award	2020-04-13	2020-04-14	75,000	—	$0	75,000	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	F Tax w/h	2020-03-20	2020-03-23	827	$2.30	$1.9K	64,983	SEC↗
RINGO WILLIAM R	Chief Executive Officer	A Award deriv	2020-03-19	2020-03-20	52,959	—	$0	52,959	SEC↗
White David	See Remarks	F Tax w/h	2020-02-28	2020-03-03	2,045	$3.83	$7.8K	42,955	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	F Tax w/h	2020-02-26	2020-02-26	1,281	$4.83	$6.2K	65,810	SEC↗
Sarena Francis Willard	Chief Strategy Officer	F Tax w/h	2020-02-26	2020-02-26	1,304	$4.83	$6.3K	105,011	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	F Tax w/h	2020-02-25	2020-02-26	1,862	$4.87	$9.1K	67,091	SEC↗
Sarena Francis Willard	Chief Strategy Officer	F Tax w/h	2020-02-25	2020-02-26	1,863	$4.87	$9.1K	106,315	SEC↗
White David	See Remarks	A Award deriv	2020-02-24	2020-02-26	25,000	—	$0	25,000	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	A Award deriv	2020-02-24	2020-02-26	90,000	—	$0	90,000	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	A Award deriv	2020-02-24	2020-02-26	90,000	—	$0	90,000	SEC↗
Sarena Francis Willard	Chief Strategy Officer	A Award deriv	2020-02-24	2020-02-26	90,000	—	$0	90,000	SEC↗
Sarena Francis Willard	Chief Strategy Officer	A Award deriv	2020-02-24	2020-02-26	90,000	—	$0	90,000	SEC↗
Smith David V	Executive Vice President & C	A Award deriv	2020-02-24	2020-03-11	90,000	—	$0	90,000	SEC↗
Smith David V	Executive Vice President & C	A Award deriv	2020-02-24	2020-03-11	90,000	—	$0	90,000	SEC↗
White David	See Remarks	A Award	2020-02-24	2020-02-26	10,000	—	$0	45,000	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	A Award	2020-02-24	2020-02-26	15,000	—	$0	68,953	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	A Award	2020-02-24	2020-02-26	15,000	—	$0	53,953	SEC↗
Sarena Francis Willard	Chief Strategy Officer	A Award	2020-02-24	2020-02-26	15,000	—	$0	108,178	SEC↗
Sarena Francis Willard	Chief Strategy Officer	A Award	2020-02-24	2020-02-26	15,000	—	$0	93,178	SEC↗
Smith David V	Executive Vice President & C	A Award	2020-02-24	2020-03-11	15,000	—	$0	48,389	SEC↗
Smith David V	Executive Vice President & C	A Award	2020-02-24	2020-03-11	15,000	—	$0	63,389	SEC↗
RINGO WILLIAM R	Chief Executive Officer	A Award deriv	2020-02-19	2020-02-20	37,998	—	$0	37,998	SEC↗
Sarena Francis Willard	Chief Strategy Officer	F Tax w/h	2020-02-05	2020-02-06	4,070	$5.13	$20.9K	78,178	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	F Tax w/h	2020-02-05	2020-02-06	5,345	$5.13	$27.4K	38,953	SEC↗
RINGO WILLIAM R	Chief Executive Officer	A Award deriv	2020-01-20	2020-01-21	40,868	—	$0	40,868	SEC↗
RINGO WILLIAM R	Chief Executive Officer	A Award deriv	2020-01-20	2020-01-21	40,868	—	$0	40,868	SEC↗
White David	See Remarks	A Award	2020-01-20	2020-02-26	20,000	—	$0	35,000	SEC↗
BVF Partners OS Ltd.	Other	P Buy	2019-12-20	2019-12-26	201,096	$4.05	$814.4K	3,078,989	SEC↗
BVF Partners OS Ltd.	Other	P Buy	2019-12-20	2019-12-26	32,606	$4.05	$132.1K	536,608	SEC↗
BVF Partners OS Ltd.	Other	P Buy	2019-12-20	2019-12-26	281,318	$4.05	$1.14M	3,929,792	SEC↗
RINGO WILLIAM R	Interim CEO	A Award deriv	2019-12-19	2019-12-20	49,552	—	$0	49,552	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2019-12-09	2019-12-11	2,397	$4.02	$9.6K	504,002	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2019-12-09	2019-12-11	18,729	$4.02	$75.3K	2,877,893	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2019-12-09	2019-12-11	113,874	$4.02	$457.8K	3,648,474	SEC↗
BERGER FRANKLIN M	Director	S Sale	2019-12-03	2019-12-04	47,890	$4.00	$191.6K	5,000	SEC↗
BERGER FRANKLIN M	Director	S Sale	2019-12-02	2019-12-04	32,090	$3.92	$125.8K	52,890	SEC↗
Smith David V	Executive Vice President & C	F Tax w/h	2019-11-26	2019-11-27	6,611	$3.77	$24.9K	33,389	SEC↗
BIOTECHNOLOGY VALUE FUND L P	Other	P Buy	2019-11-22	2019-11-26	462,056	$3.40	$1.57M	2,859,164	SEC↗
BIOTECHNOLOGY VALUE FUND L P	Other	P Buy	2019-11-22	2019-11-26	81,857	$3.40	$278.3K	501,605	SEC↗
BIOTECHNOLOGY VALUE FUND L P	Other	P Buy	2019-11-22	2019-11-26	576,097	$3.40	$1.96M	3,534,600	SEC↗
RINGO WILLIAM R	Interim CEO	A Award deriv	2019-11-19	2019-11-20	50,367	—	$0	50,367	SEC↗
BIOTECHNOLOGY VALUE FUND II LP	Other	P Buy	2019-11-05	2019-11-07	400,470	$4.00	$1.60M	2,397,108	SEC↗
BIOTECHNOLOGY VALUE FUND II LP	Other	P Buy	2019-11-05	2019-11-07	496,721	$4.00	$1.99M	2,958,503	SEC↗
BIOTECHNOLOGY VALUE FUND II LP	Other	P Buy	2019-11-05	2019-11-07	70,921	$4.00	$283.7K	419,748	SEC↗
LAMPERT MARK N	10% Owner	P Buy	2019-10-31	2019-10-31	3,416	$3.85	$13.2K	2,461,782	SEC↗
LAMPERT MARK N	10% Owner	P Buy	2019-10-31	2019-10-31	2,913	$3.85	$11.2K	1,996,638	SEC↗
LAMPERT MARK N	10% Owner	P Buy	2019-10-31	2019-10-31	504	$3.85	$1.9K	348,827	SEC↗
LAMPERT MARK N	10% Owner	P Buy	2019-10-30	2019-10-31	10,389	$3.89	$40.4K	2,458,366	SEC↗
LAMPERT MARK N	10% Owner	P Buy	2019-10-30	2019-10-31	8,236	$3.89	$32.0K	1,993,725	SEC↗
LAMPERT MARK N	10% Owner	P Buy	2019-10-30	2019-10-31	1,456	$3.89	$5.7K	348,323	SEC↗
LAMPERT MARK N	10% Owner	P Buy	2019-10-29	2019-10-31	1,027	$3.90	$4.0K	2,447,977	SEC↗
LAMPERT MARK N	10% Owner	P Buy	2019-10-29	2019-10-31	1,133	$3.90	$4.4K	1,985,489	SEC↗
LAMPERT MARK N	10% Owner	P Buy	2019-10-29	2019-10-31	240	$3.90	$936	346,867	SEC↗
BVF INC/IL	10% Owner	P Buy	2019-10-25	2019-10-25	12,899	$3.75	$48.4K	1,984,356	SEC↗
BVF INC/IL	10% Owner	P Buy	2019-10-25	2019-10-25	2,155	$3.75	$8.1K	346,627	SEC↗
BVF INC/IL	10% Owner	P Buy	2019-10-25	2019-10-25	15,728	$3.75	$59.0K	2,446,950	SEC↗
BVF INC/IL	10% Owner	P Buy	2019-10-24	2019-10-25	76,036	$3.74	$284.4K	2,431,222	SEC↗
BVF INC/IL	10% Owner	P Buy	2019-10-24	2019-10-25	1,629	$3.74	$6.1K	344,472	SEC↗
BVF INC/IL	10% Owner	P Buy	2019-10-24	2019-10-25	57,723	$3.74	$215.9K	1,971,457	SEC↗
BVF INC/IL	10% Owner	P Buy	2019-10-23	2019-10-25	3,200	$3.75	$12.0K	2,355,186	SEC↗
RINGO WILLIAM R	Interim CEO	A Award deriv	2019-10-19	2019-10-21	46,939	—	$0	46,939	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2019-10-08	2019-10-08	4,689	$3.68	$17.3K	342,843	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2019-10-08	2019-10-08	24,716	$3.68	$91.0K	1,913,734	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2019-10-08	2019-10-08	31,007	$3.68	$114.1K	2,351,986	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2019-10-07	2019-10-08	14,242	$3.75	$53.4K	313,729	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2019-10-07	2019-10-08	98,333	$3.75	$368.7K	2,152,339	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2019-10-07	2019-10-08	138,609	$3.75	$519.8K	1,889,018	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2019-10-07	2019-10-08	80,821	$3.75	$303.1K	1,750,409	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2019-10-07	2019-10-08	168,640	$3.75	$632.4K	2,320,979	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2019-10-07	2019-10-08	24,425	$3.75	$91.6K	338,154	SEC↗
RINGO WILLIAM R	Interim CEO	A Award deriv	2019-10-05	2019-10-08	34,451	—	$0	34,451	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2019-10-04	2019-10-08	7,695	$3.74	$28.8K	2,054,006	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2019-10-04	2019-10-08	7,314	$3.74	$27.4K	1,669,588	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2019-10-04	2019-10-08	991	$3.74	$3.7K	299,487	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	F Tax w/h	2019-09-01	2019-09-04	496	$5.43	$2.7K	44,298	SEC↗
Sarena Francis Willard	Chief Strategy Officer	F Tax w/h	2019-09-01	2019-09-04	2,811	$5.43	$15.3K	82,248	SEC↗
Knickerbocker Aron Marc	President & CEO	F Tax w/h	2019-09-01	2019-09-04	3,306	$5.43	$18.0K	42,057	SEC↗
Williams Lewis T	Director	F Tax w/h	2019-09-01	2019-09-04	7,024	$5.43	$38.1K	455,336	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	A Award deriv	2019-08-20	2019-08-22	20,000	—	$0	20,000	SEC↗
Collins Helen Louise	EVP and Chief Medical Office	A Award	2019-08-20	2019-08-22	5,000	—	$0	44,794	SEC↗
Smith David V	Executive Vice President & C	A Award deriv	2019-06-24	2019-06-26	44,000	—	$0	44,000	SEC↗
Collins Helen Louise	SVP and Chief Medical Office	A Award deriv	2019-06-24	2019-06-26	44,000	—	$0	44,000	SEC↗
Sarena Francis Willard	Chief Strategy Officer	A Award deriv	2019-06-24	2019-06-26	44,000	—	$0	44,000	SEC↗
Knickerbocker Aron Marc	President & CEO	A Award deriv	2019-06-24	2019-06-26	124,420	—	$0	124,420	SEC↗
Lyons-Williams Lori	Director	A Award deriv	2019-06-23	2019-06-25	25,000	—	$0	25,000	SEC↗
Dhingra Kapil	Director	A Award deriv	2019-06-10	2019-06-12	15,000	—	$0	15,000	SEC↗
Jensen Peder	Director	A Award deriv	2019-06-10	2019-06-12	15,000	—	$0	15,000	SEC↗
Nicholson Garry A	Director	A Award deriv	2019-06-10	2019-06-12	15,000	—	$0	15,000	SEC↗
BERGER FRANKLIN M	Director	A Award deriv	2019-06-10	2019-06-12	15,000	—	$0	15,000	SEC↗
RINGO WILLIAM R	Director	A Award deriv	2019-06-10	2019-06-12	15,000	—	$0	15,000	SEC↗
SCHAFER CAROL	Director	A Award deriv	2019-06-10	2019-06-12	1,250	—	$0	1,250	SEC↗
Williams Lewis T	Director	A Award deriv	2019-06-10	2019-06-12	15,000	—	$0	15,000	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise deriv	2019-06-07	2019-06-10	11,357	—	$0	0	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise	2019-06-07	2019-06-10	11,357	$5.54	$62.9K	195,828	SEC↗
SCHAFER CAROL	Director	A Award deriv	2019-05-15	2019-05-16	25,000	—	$0	25,000	SEC↗
Irving Bryan	EVP, Chief Scientific Office	F Tax w/h	2019-05-15	2019-05-16	620	$9.17	$5.7K	30,533	SEC↗
White David	See Remarks	A Award deriv	2019-02-28	2019-03-04	30,000	—	$0	30,000	SEC↗
White David	See Remarks	A Award	2019-02-28	2019-03-04	15,000	—	$0	15,000	SEC↗
Williams Lewis T	Director	F Tax w/h	2019-02-26	2019-02-27	926	$11.95	$11.1K	461,360	SEC↗
Sarena Francis Willard	Chief Strategy Officer	F Tax w/h	2019-02-26	2019-02-27	1,194	$11.95	$14.3K	82,955	SEC↗
Collins Helen Louise	SVP and Chief Medical Office	F Tax w/h	2019-02-26	2019-02-27	1,177	$11.95	$14.1K	39,794	SEC↗
Irving Bryan	EVP, Chief Scientific Office	F Tax w/h	2019-02-26	2019-02-27	1,118	$11.95	$13.4K	31,153	SEC↗
Knickerbocker Aron Marc	President & CEO	F Tax w/h	2019-02-26	2019-02-27	2,462	$11.95	$29.4K	218,445	SEC↗
Sarena Francis Willard	Chief Strategy Officer	A Award deriv	2019-02-25	2019-02-27	58,000	—	$0	58,000	SEC↗
Collins Helen Louise	SVP and Chief Medical Office	A Award deriv	2019-02-25	2019-02-27	58,000	—	$0	58,000	SEC↗
Irving Bryan	EVP, Chief Scientific Office	A Award deriv	2019-02-25	2019-02-27	58,000	—	$0	58,000	SEC↗
Knickerbocker Aron Marc	President & CEO	A Award deriv	2019-02-25	2019-02-27	156,910	—	$0	156,910	SEC↗
Williams Lewis T	Director	A Award deriv	2019-02-25	2019-02-28	6,400	—	$0	6,400	SEC↗
Sarena Francis Willard	Chief Strategy Officer	A Award	2019-02-25	2019-02-27	10,000	—	$0	84,149	SEC↗
Collins Helen Louise	SVP and Chief Medical Office	A Award	2019-02-25	2019-02-27	10,000	—	$0	40,971	SEC↗
Irving Bryan	EVP, Chief Scientific Office	A Award	2019-02-25	2019-02-27	10,000	—	$0	32,271	SEC↗
Knickerbocker Aron Marc	President & CEO	A Award	2019-02-25	2019-02-27	25,844	—	$0	220,907	SEC↗
Williams Lewis T	Director	A Award	2019-02-25	2019-02-28	1,000	—	$0	462,360	SEC↗
Knickerbocker Aron Marc	President & CEO	F Tax w/h	2019-02-05	2019-02-07	2,996	$11.43	$34.2K	195,063	SEC↗
Williams Lewis T	Director	F Tax w/h	2019-02-05	2019-02-07	3,144	$11.43	$35.9K	462,286	SEC↗
Collins Helen Louise	SVP and Chief Medical Office	F Tax w/h	2019-02-05	2019-02-07	3,196	$11.43	$36.5K	30,971	SEC↗
Sarena Francis Willard	Chief Strategy Officer	F Tax w/h	2019-02-05	2019-02-07	2,996	$11.43	$34.2K	74,149	SEC↗
RINGO WILLIAM R	Director	A Award	2019-01-09	2019-01-11	10,000	—	$0	10,000	SEC↗
Smith David V	Executive Vice President & C	A Award deriv	2018-11-26	2018-11-27	185,000	—	$0	185,000	SEC↗
Smith David V	Executive Vice President & C	A Award	2018-11-26	2018-11-27	40,000	—	$0	40,000	SEC↗
Williams Lewis T	Executive Chairman	M Exercise deriv	2018-11-05	2018-11-13	91,217	—	$0	0	SEC↗
Williams Lewis T	Executive Chairman	M Exercise	2018-11-05	2018-11-13	91,217	$4.56	$415.9K	465,430	SEC↗
Collins Helen Louise	SVP and Chief Medical Office	A Award	2018-09-28	2018-10-02	3,844	—	$0	36,073	SEC↗
Collins Helen Louise	SVP and Chief Medical Office	F Tax w/h	2018-09-28	2018-10-02	1,906	$13.92	$26.5K	34,167	SEC↗
Sarena Francis Willard	Chief Strategy Officer	F Tax w/h	2018-09-28	2018-10-02	954	$13.92	$13.3K	77,145	SEC↗
Sarena Francis Willard	Chief Strategy Officer	A Award	2018-09-28	2018-10-02	1,923	—	$0	78,099	SEC↗
Knickerbocker Aron Marc	President & CEO	F Tax w/h	2018-09-28	2018-10-02	954	$13.92	$13.3K	196,966	SEC↗
Knickerbocker Aron Marc	President & CEO	A Award	2018-09-28	2018-10-02	1,775	—	$0	197,920	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise deriv	2018-09-26	2018-09-27	584	$11.14	$6.5K	31,595	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise	2018-09-26	2018-09-27	584	$11.14	$6.5K	196,145	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise deriv	2018-09-24	2018-09-25	500	$11.14	$5.6K	32,179	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise	2018-09-24	2018-09-25	500	$11.14	$5.6K	195,561	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise deriv	2018-09-19	2018-09-20	500	$11.14	$5.6K	32,679	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise	2018-09-19	2018-09-20	500	$11.14	$5.6K	195,061	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise deriv	2018-09-17	2018-09-18	500	$11.14	$5.6K	33,179	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise	2018-09-17	2018-09-18	500	$11.14	$5.6K	194,561	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise deriv	2018-09-12	2018-09-12	1,000	$11.14	$11.1K	33,679	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise	2018-09-12	2018-09-12	1,000	$11.14	$11.1K	194,061	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise deriv	2018-09-05	2018-09-06	500	$11.14	$5.6K	34,679	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise	2018-09-05	2018-09-06	500	$11.14	$5.6K	193,061	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise deriv	2018-09-04	2018-09-05	500	$11.14	$5.6K	35,179	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise	2018-09-04	2018-09-05	500	$11.14	$5.6K	192,561	SEC↗
Collins Helen Louise	SVP and Chief Medical Office	F Tax w/h	2018-09-01	2018-09-05	496	$14.00	$6.9K	32,229	SEC↗
Irving Bryan	EVP, Chief Scientific Office	F Tax w/h	2018-09-01	2018-09-05	2,479	$14.00	$34.7K	22,271	SEC↗
Sarena Francis Willard	Chief Strategy Officer	F Tax w/h	2018-09-01	2018-09-05	2,810	$14.00	$39.3K	76,177	SEC↗
Williams Lewis T	Executive Chairman	F Tax w/h	2018-09-01	2018-09-05	7,024	$14.00	$98.3K	374,213	SEC↗
Knickerbocker Aron Marc	President & CEO	F Tax w/h	2018-09-01	2018-09-05	3,306	$14.00	$46.3K	192,061	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise deriv	2018-08-27	2018-08-28	500	$11.14	$5.6K	35,679	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise	2018-08-27	2018-08-28	500	$11.14	$5.6K	195,367	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise deriv	2018-08-22	2018-08-23	500	—	$0	36,179	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise	2018-08-22	2018-08-23	500	$11.14	$5.6K	194,867	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise deriv	2018-08-21	2018-08-22	500	—	$0	36,679	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise	2018-08-21	2018-08-22	500	$11.14	$5.6K	194,367	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise deriv	2018-08-20	2018-08-21	500	—	$0	37,179	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise	2018-08-20	2018-08-21	500	$11.14	$5.6K	193,867	SEC↗
Knickerbocker Aron Marc	President & CEO	M Exercise deriv	2018-08-15	2018-08-16	500	—	$0	37,679	SEC↗